macrolones (GlaxoSmithKline/Fidelta)

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug Namemacrolones (GlaxoSmithKline/Fidelta)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesCroatia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRyvu Therapeutics SaGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A